Curtis Cooper trained at the University of Saskatchewan (MD 1994). He received certification in
Internal Medicine in 1997 and in Infectious Diseases in 1999 while at the University of Manitoba.
He completed an HIV Research Fellowship and Masters of Epidemiology in 2002 while at the
University of Ottawa. He is currently a Professor with the University of Ottawa, Senior Clinician Scientist with the Ottawa Health Research Institute and Head- The Ottawa Hospital Division of Infectious Diseases. His research activities encompass viral hepatitis, HIV co-infections and vaccine development. His work is focused on the development of viral hepatitis therapeutic agents and the delivery of treatments that maximizes safety, adherence and effectiveness. He also oversees multiple national and provincial cohort studies related to HBV, HCV, HIV and COVID19.

I have/had an affiliation (financial or otherwise) with a for-profit or not-for-profit organization.
- Currently participating, or have participated, in a clinical trial within the past two years: Yes
- Member of an advisory board or speakers’ bureau: Gliead/GSK
- Received/will receive a grant or an honorarium from a for-profit or not-for-profit organization: Gilead/GSK

I intend to make therapeutic recommendations for medications that have not received regulatory approval (ie, “off-label” use of medications).